Publication | Closed Access

Warfarin and Antiplatelet Combination Use Among Commercially Insured Patients Enrolled in an Anticoagulation Management Service

Anticoagulation Management ServiceThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyBlood PlateletHematologyPatient SafetyPublic HealthPlatelet AntagonistMedicineAnticoagulantAntiplatelet Combination UseEmergency Medicine